Publications

• Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
  N Engl J Med Volume: 390 Page(s): 1105 - 1117
  03/21/2024 Authors: Cheng A; Kashyap A; Salvator H; Rosen LB; Colby D; Ardeshir-Larijani F; Loehrer PJ; Ding L; Lugo Reyes SO; Riminton S
• Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report.
  Clin Lung Cancer Volume: 25 Page(s): 180 - 185.e1
  03/01/2024 Authors: Ardeshir-Larijani F; Maniar R; Goyal S; Loehrer PJ; Hou T; DeBrock V; Mesa H
• Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
  JCO Precis Oncol Volume: 7 Page(s): e2200465
  02/01/2023 Authors: Ardeshir-Larijani F; Schneider BP; Althouse SK; Radovich M; Masood A; Perna F; Salman H; Loehrer PJ
• A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139.
  Clin Lung Cancer Volume: 23 Page(s): 578 - 584
  11/01/2022 Authors: Ardeshir-Larijani F; Althouse SK; Leal T; Feldman LE; Hejleh TA; Patel M; Gentzler RD; Miller AR; Hanna NH
• Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
  Clin Lung Cancer Volume: 22 Page(s): 16 - 22.e1
  01/01/2021 Authors: Al-Ahmadi A; Ardeshir-Larijani F; Fu P; Cao S; Lipka MB; Dowlati A; Bruno DS
• Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy.
  Volume: 37
  05/20/2019 Authors: Ardeshir-Larijani F; Nelson AA; Martin P; Mendiratta P; Sloan AE; Choi S; Mansur DB; Hoimes CJ
• Development of a prognostic risk model for small cell lung cancer: Identification of high-, intermediate-, and low-risk cohorts based on clinical-genomic data.
  Volume: 37
  05/20/2019 Authors: Ardeshir-Larijani F; Wildey G; Fu P; Dowlati A
• Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
  Cancer Med Volume: 8 Page(s): 1459 - 1466
  04/01/2019 Authors: Bhateja P; Chiu M; Wildey G; Lipka MB; Fu P; Yang MCL; Ardeshir-Larijani F; Sharma N; Dowlati A
• KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
  Clin Lung Cancer Volume: 19 Page(s): e489 - e501
  07/01/2018 Authors: Ardeshir-Larijani F; Bhateja P; Lipka MB; Sharma N; Fu P; Dowlati A
• Frequency of NOTCH pathway mutation in primary tumor of SCLC compared to metastatic biopsies and association with better survival.
  Volume: 36
  05/20/2018 Authors: Ardeshir-Larijani F; Wildey G; Fu P; Bhateja P; Dowlati A
• Effects of comprehensive genomic testing in a large non-small cell cancer NSCLC cohort: Racial and survival impacts.
  Volume: 36
  05/20/2018 Authors: Ardeshir-Larijani F; Alahmadi A; Fu P; Wildey G; Lipka MB; Dowlati A
• Location of Death Among Patients Who Die from Lung Cancer in the United States: Analysis of the Multiple Cause of Mortality
  Volume: 197
  01/01/2018 Authors: Ardeshir-Larijani F; Schuster J; Dolan C; Yaqoob Z; Dowlati A
• Retinoblastoma mutation to predict poor outcomes in non-small cell lung cancer (NSCLC).
  Volume: 35
  05/20/2017 Authors: Bhateja P; Wildey G; Fu P; Lipka MB; Ardeshir-Larijani F; Sharma N; Dowlati A
• The trend of national and sub-national burden of gastrointestinal and liver diseases in Iran 1990 to 2013; study protocol.
  Arch Iran Med Volume: 17 Page(s): 33 - 53
  01/01/2014 Authors: Salimzadeh H; Ardeshir Larijani F; Abedian S; Kalantar Motamedi SM; Malekzadeh MM; Mohaghegh H; Sadeghi A; Sepanlou SG; Delavari A; Saberi-Firoozi M
• The relation between serum vitamin D levels and blood pressure: a population-based study.
  Acta Med Iran Volume: 52 Page(s): 290 - 297
  01/01/2014 Authors: Ardeshir Larijani F; Kalantar Motamedi SM; Keshtkar AA; Khashayar P; Koleini Z; Rahim F; Larijani B
• A supplemental video teaching tool enhances splinting skills.
  Clin Orthop Relat Res Volume: 471 Page(s): 649 - 654
  02/01/2013 Authors: Mehrpour SR; Aghamirsalim M; Motamedi SMK; Ardeshir Larijani F; Sorbi R